Phibro Animal Health Corp. (PAHC)
38.82
+0.84
(+2.21%)
USD |
NASDAQ |
Oct 16, 16:00
38.83
+0.01
(+0.03%)
After-Hours: 20:00
Phibro Animal Health Free Cash Flow : 9.866M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.866M |
| March 31, 2026 | 12.77M |
| December 31, 2025 | 47.29M |
| September 30, 2025 | 34.29M |
| June 30, 2025 | 41.83M |
| March 31, 2025 | 49.06M |
| December 31, 2024 | 15.33M |
| September 30, 2024 | 40.67M |
| June 30, 2024 | 46.36M |
| March 31, 2024 | 40.35M |
| December 31, 2023 | 37.02M |
| September 30, 2023 | 4.113M |
| June 30, 2023 | -38.48M |
| March 31, 2023 | -58.15M |
| December 31, 2022 | -60.38M |
| September 30, 2022 | -35.64M |
| June 30, 2022 | -5.395M |
| March 31, 2022 | 0.897M |
| December 31, 2021 | 13.92M |
| September 30, 2021 | 21.08M |
| June 30, 2021 | 18.99M |
| March 31, 2021 | 16.81M |
| December 31, 2020 | 26.77M |
| September 30, 2020 | 30.83M |
| June 30, 2020 | 25.30M |
| Date | Value |
|---|---|
| March 31, 2020 | 36.26M |
| December 31, 2019 | 25.16M |
| September 30, 2019 | 10.80M |
| June 30, 2019 | 17.28M |
| March 31, 2019 | 17.10M |
| December 31, 2018 | 27.74M |
| September 30, 2018 | 46.89M |
| June 30, 2018 | 51.46M |
| March 31, 2018 | 54.95M |
| December 31, 2017 | 68.58M |
| September 30, 2017 | 61.76M |
| June 30, 2017 | 77.50M |
| March 31, 2017 | 88.32M |
| December 31, 2016 | 50.08M |
| September 30, 2016 | 26.90M |
| June 30, 2016 | 0.866M |
| March 31, 2016 | -3.115M |
| December 31, 2015 | 18.56M |
| September 30, 2015 | 24.77M |
| June 30, 2015 | 48.65M |
| March 31, 2015 | 10.80M |
| December 31, 2014 | -9.155M |
| September 30, 2014 | -2.73M |
| June 30, 2014 | -20.56M |
| March 31, 2014 | 5.498M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Globus Medical, Inc. | 750.84M |
| Corcept Therapeutics, Inc. | 106.92M |
| Zoetis, Inc. | 2.366B |
| Abbott Laboratories | 7.824B |
| Prestige Consumer Healthcare, Inc. | 235.36M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 24.09M |
| Cash from Investing (Quarterly) | -16.45M |
| Cash from Financing (Quarterly) | -1.615M |
| Free Cash Flow Per Share (Quarterly) | 0.1274 |
| Free Cash Flow to Equity (Quarterly) | 3.902M |
| Free Cash Flow to Firm (Quarterly) | 5.579M |
| Free Cash Flow Yield | 0.62% |